NASDAQ:INPX - Inpixon Stock Price, Forecast & News

Inpixon trades on the NASDAQ under the ticker symbol "INPX."

Inpixon's stock reverse split on Friday, November 2nd 2018. The 1-40 reverse split was announced on Thursday, November 1st 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, November 1st 2018. An investor that had 100 shares of Inpixon stock prior to the reverse split would have 3 shares after the split.

Inpixon (NASDAQ:INPX) issued its earnings results on Thursday, August, 11th. The technology company reported ($132.00) EPS for the quarter, missing the Zacks' consensus estimate of ($96.00) by $36.00. The technology company had revenue of $13.30 million for the quarter, compared to the consensus estimate of $16.90 million. Inpixon had a negative net margin of 462.40% and a negative return on equity of 202.01%. View Inpixon's Earnings History.

Inpixon is scheduled to release their next quarterly earnings announcement on Tuesday, March 24th 2020. View Earnings Estimates for Inpixon.

Headlines about INPX stock have been trending negative on Thursday, according to InfoTrie. The research group identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Inpixon earned a news sentiment score of -2.2 on InfoTrie's scale. They also assigned media headlines about the technology company a news buzz of 9.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for Inpixon.

Some companies that are related to Inpixon include Infosys (INFY), Cognizant Technology Solutions (CTSH), Verisign (VRSN), Wipro (WIT), NTT DATA CORP/ADR (NTDTY), Obic (OBIIF), EPAM Systems (EPAM), Amdocs (DOX), Aspen Technology (AZPN), Zscaler (ZS), GEMALTO NV/S (GTOMY), Endava (DAVA), PROS (PRO), Perficient (PRFT) and Sogou (SOGO).

Based on aggregate information from My MarketBeat watchlists, some companies that other Inpixon investors own include Onconova Therapeutics (ONTX), Biocept (BIOC), Co-Diagnostics (CODX), FuelCell Energy (FCEL), Ibio (IBIO), Digital Ally (DGLY), Advanced Micro Devices (AMD), Microvision (MVIS), Precipio (PRPO) and Nokia Oyj (NOK).

Inpixon's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Barclays PLC (23.55%) and UBS Group AG (13.45%). View Institutional Ownership Trends for Inpixon.

INPX stock was bought by a variety of institutional investors in the last quarter, including Barclays PLC and UBS Group AG. View Insider Buying and Selling for Inpixon.

Shares of INPX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of INPX stock can currently be purchased for approximately $2.55.

Inpixon has a market capitalization of $3.75 million and generates $3.76 million in revenue each year. Inpixon employs 68 workers across the globe.View Additional Information About Inpixon.

The official website for Inpixon is http://www.inpixon.com/.

Inpixon's mailing address is 2479 E. BAYSHORE ROAD SUITE 195, PALO ALTO CA, 94303. The technology company can be reached via phone at 408-702-2167 or via email at [email protected]